Liso-Cel Generates Responses in R/R Marginal Zone Lymphoma
FDA Grants Fast Track Designation to Amezalpat for Hepatocellular Carcinoma
Bladder Cancer Care Shifts as BCG Shortage Lingers, With Investigative Combinations and Tools at the Forefront
Acalabrutinib Plus Venetoclax/Obinutuzumab Demonstrates Efficacy, Safety in Mantle Cell Lymphoma